Pharmafile Logo
Pharmafocus logo
Advanced Search

Amicus

Showing 3 posts of 3 posts found.

shutterstock_159488225

Amicus pulls plug on rare skin disease drug after Phase 3 failure

September 14, 2017
Research and Development Amicus, epidermolysis bullosa, pharma, pharmaceutical, trial failure

New Jersey-based biotech firm Amicus Therapeutics has been forced to terminate its development of its candidate for treating rare skin …

News
biogen_idec_ten_cambridge_center

Amicus links with Biogen Idec

September 12, 2013
Research and Development, Sales and Marketing Amicus, Biogen IDEC, Parkinson's

Amicus Therapeutics and Biogen Idec have signed a collaboration agreement which will see them look for novel small molecules for …

News
gsk image

GSK raises stake in Amicus for Fabry drug

July 18, 2012
Research and Development, Sales and Marketing Amicus, Fabry, GSK, R&D

GlaxoSmithKline is to increase ownership in Amicus Therapeutics as the firms extend their collaboration to find a new drug for …

News

Latest content

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024

FDA approves ImmunityBio’s Anktiva bladder cancer treatment

April 23, 2024

EC approves Pfizer’s Emblaveo for multidrug-resistant infection treatment

April 22, 2024

Neurolentech and Kaerus Bioscience enter partnership for research on neurodevelopmental disorder

April 22, 2024

Ardena announces €20m expansion following first GMP approval

April 19, 2024